Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 424 of 5804
-
Could this drug slow Alzheimer's brain damage?
Disease control Recruiting nowResearchers want to know if the study treatment called MK-2214 works to slow certain changes in the brains of people with Alzheimer's disease (AD). AD is a type of dementia that can cause loss of memory, communication (such as speech), and decision-making skills. It can limit a p…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New triple therapy aims to tame relapsed blood cancer
Disease control Recruiting nowTo learn if the drug combination pirtobrutinib, venetoclax, and obinutuzumab can help to control relapsed CLL/SLL.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New hope for hard-to-treat cancers: triple-drug combo targets HER2-positive tumors
Disease control Recruiting nowhis single-center phase II clinical study enrolls patients with unresectable locally advanced or metastatic HER2-overexpressing biliary tract cancer or urothelial carcinoma who have failed standard treatment. Participants receive trastuzumab in combination with serplulimab and ch…
Phase: PHASE2 • Sponsor: Xiujuan Qu • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Engineered immune cells take on tough leukemia
Disease control Recruiting nowThis study will evaluate safety and efficacy of a combination of 4th generation chimeric antigen receptor gene-modified T cells targeting CD19 negative ALL that express CD22, CD123, CD38, CD10, CD20 and TSLPR, as many patients developed CD19-negative disease after CD19 CART immun…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Engineered immune cells take on tough leukemia
Disease control Recruiting nowThe purpose of this clinical trial is to assess the feasibility, safety and efficacy of multi-CAR T cell therapy targeting different AML surface antigens in patients with relapsed or refractory acute myeloid leukemia (AML). Another goal of the study is to learn more about the fun…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Zapping the brain: new hope for stroke patients who can't get standard treatment
Disease control Recruiting nowMany patients with acute ischemic stroke are ineligible for currently available standard treatments (clot-busting medication, also known as intravenous thrombolytic or mechanical removal of a clot), and many are non-responders, resulting in a low rate of excellent outcomes, which…
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can a simple inhaled antibiotic stop ventilator pneumonia?
Prevention Recruiting nowPrevious studies have identified Acinetobacter baumannii (AB), Pseudomonas aeruginosa (PA), and Klebsiella pneumoniae (KP) as the predominant pathogens responsible for ventilator-associated pneumonia (VAP). The challenge of drug resistance, especially against carbapenem is intens…
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
New implant aims to release trapped air in lungs of COPD patients
Disease control Recruiting nowThe objective of this study is to assess the safety and efficacy of Apreo BREATHE system when used to support native airways and release trapped air in the treatment of adult COPD patients with emphysema suffering from dyspnea due to hyperinflation despite optimal medical treatme…
Phase: NA • Sponsor: Apreo Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug aims to protect kidneys in IgA nephropathy patients
Disease control Recruiting nowImmunoglobulin A nephropathy (IgAN) is a kidney condition. It happens when the body's immune system creates groups of proteins (called immune complexes) that build-up in the kidneys causing swelling (inflammation). Over time, this inflammation may lead to kidney damage and cause …
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New hope for tough lung cancers: dual-antibody combo targets tumors from two angles
Disease control Recruiting nowThis is a multiple-arm, open phase II clinical trial evaluating the safety, tolerability,and preliminary efficacy of JS207 in NSCLC after progression following Platinum-based chemotherapy and immunotherapy.
Phase: PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Engineered immune cells take aim at stubborn blood cancers
Disease control Recruiting nowCAR-T cell treatment of refractory lymphoma has shown success, particularly with CD-19 targeted CAR-T cells, however, many participants are refractory or relapse after response. Responses are more limited in CLL/SLL, possibly secondary to the suppressive effect of circulating B c…
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Nose cartilage could fix your knee: new trial underway
Disease control Recruiting nowENCANTO is a randomized, controlled, multi-center phase II clinical trial for the treatment of patellofemoral osteoarthritis (PFOA) with an Advanced Therapy Medicinal Product (ATMP), nasal chondrocyte-based tissue engineered cartilage (N-TEC) implantation in comparison with curre…
Phase: PHASE2 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Glowing probe could spare gastric cancer patients unnecessary lymph node removal
Diagnosis Recruiting nowWith the widespread adoption of early cancer screening, the proportion of early gastric cancer (EGC) in China has been gradually increasing. The primary treatments for EGC are endoscopic and surgical interventions. For EGC invading the submucosal layer, the lymph node metastasis …
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Gene therapy hope for kids and adults with rare Blindness-Causing mutation
Disease control Recruiting nowAdministering subretinal injection of LX107 injection (a gene therapy drug) to patients with retinal dystrophy caused by AIPL1 gene mutation to evaluate its efficacy and safety.
Phase: EARLY_PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Heart attack timing trial: quicker scans may save lives in heart failure patients
Disease control Recruiting nowStudy objectives: To determine the optimal timing of coronary angiography (CAG) in patients with non-ST-segment elevation myocardial infarction (NSTEMI) complicated by acute decompensated heart failure (AHF). The primary objective of this trial is to test the hypothesis that imm…
Phase: NA • Sponsor: Chonnam National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug cocktail aims to shrink brain tumors in breast cancer patients
Disease control Recruiting nowThis study is a multicenter, two-stage clinical trial to evaluate the efficacy and safety of utidelone in combination with capecitabine in patients with HER2-negative breast cancer with brain metastases. Patients will be enrolled to receive treatment of utidelone alone or in comb…
Phase: PHASE2 • Sponsor: Biostar Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New device aims to safely drain fluid in heart failure patients
Disease control Recruiting nowThe objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute decompensated heart failure (ADHF). The main objective is to determine if the Repri…
Phase: PHASE3 • Sponsor: Reprieve Cardiovascular, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug combo shows promise for Hard-to-Treat stomach cancer
Disease control Recruiting nowGastrointestinal stromal tumors (GISTs) are mostly driven by c-kit or PDGFRA mutations, and commonly occur in the stomach and small intestine. Targeted therapy is the mainstay for advanced metastatic GISTs, but there is a lack of effective regimens after drug resistance. Immune c…
Phase: PHASE2 • Sponsor: Jian Li • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug aims to rescue platelet levels in leukemia patients
Disease control Recruiting nowEvaluation of the Efficacy and Safety of Romiplostim N01 for the Treatment of Cancer Treatment-Induced Thrombocytopenia (CTIT) in Patients with Leukemia
Phase: PHASE2 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug combo aims to boost brain function in Alzheimer's patients
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC